Position in CRNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$36,476,303
+$5,920,254 QoQ
Shares Held
974,781
+15.9% QoQ
Ownership
0.919%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. CRNX ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,476,303 | 974,781 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $30,556,049 | 841,301 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $35,835,257 | 769,823 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $33,731,832 | 809,888 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $22,553,962 | 784,213 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $28,746,493 | 857,081 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,984,887 | 879,814 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $37,329,367 | 730,516 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $27,144,396 | 606,037 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $28,150,784 | 601,384 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $21,434,173 | 602,422 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,764,415 | 597,324 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,842,953 | 490,730 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,665,244 | 477,288 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,798,639 | 480,800 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,395,421 | 478,382 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,031,840 | 484,281 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,669,500 | 440,524 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,799,498 | 450,528 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $7,725,327 | 366,999 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,901,245 | 366,114 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,513,603 | 295,393 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $4,480,430 | 317,536 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,103,419 | 325,681 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,677,972 | 209,930 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,386,469 | 162,345 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||